Condition

Telangiectasia, Hereditary Hemorrhagic clinical trials and research

As of November 12, 2026, Find a Trial lists 3 Telangiectasia, Hereditary Hemorrhagic clinical trials that are recruiting, at sites in 3 countries (most in United Kingdom (2), France (1), Switzerland (1)). By phase: Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.

Newest Telangiectasia, Hereditary Hemorrhagic clinical trials

StudyPhaseWhereStatusRegistered
Using nintedanib to treat nosebleeds in patients with hereditary hemorrhagic telangiectasia Phase 2 Bron and 2 other locations Recruiting Jul 26, 2021
Review of medical records for patients with hereditary bleeding disorders — London Recruiting Oct 3, 2005
Examining genes in families affected by hereditary hemorrhagic telangiectasia — London Recruiting Oct 3, 2005

All recruiting trials (3)

Quick answers

How many Telangiectasia, Hereditary Hemorrhagic clinical trials are recruiting right now?

3, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 3 countries. The most sites are in United Kingdom (2 trials), France (1 trial), Switzerland (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →

Last reviewed 2026-11-12 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.